Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
100%(6 trials)

Phase Distribution

Ph phase_3
3
50%
Ph phase_2
2
33%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 33 (50.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

NCT01840605
completedphase_3

The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

NCT01861522
completedphase_3

A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

NCT01900054
completedphase_1

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+

NCT04693429
completedphase_2

Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)

NCT01753739
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01840605Phase 3

A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

Completed
NCT01861522Phase 3

The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Completed
NCT01900054Phase 3

A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Completed
NCT04693429Phase 1

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+

Completed
NCT01753739Phase 2

Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)

Completed
NCT00424398Phase 2

Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6